Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1981 Aug;12(2):189–193. doi: 10.1111/j.1365-2125.1981.tb01199.x

Radioimmunoassay for trifluoperazine in human plasma.

K K Midha, J W Hubbard, J K Cooper, E M Hawes, S Fournier, P Yeung
PMCID: PMC1401876  PMID: 7306433

Abstract

1 A new sensitive and rapid radioimmunoassay procedure for the determination of the plasma concentrations of the neuroleptic drug trifluoperazine is described. 2 The antiserum developed for trifluoperazine cross-reacted with N-desmethyltrifluoperazine and 7-hydroxytrifluoperazine to the extent of 26 and 24% respectively but its cross-reactivity with commonly co-administered tricyclic antidepressants and antianxiety agents tested was negligible. 3 The assay, based on the above antiserum, enabled the quantitation of 50 pg of the drug in 200 microliters of plasma with a coefficient of variation of about 2% and therefore should be applicable for singly dose pharmacokinetic and bioavailability studies. It should be applicable to therapeutic monitoring of the drug in patients.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham G. E. Solid-phase radioimmunoassay of estradiol-17 beta. J Clin Endocrinol Metab. 1969 Jun;29(6):866–870. doi: 10.1210/jcem-29-6-866. [DOI] [PubMed] [Google Scholar]
  2. Breyer U., Gaertner H. J., Prox A. Formation of identical metabolites from piperazine- and dimethylamino-substituted phenothiazine drugs in man, rat and dog. Biochem Pharmacol. 1974 Jan 15;23(2):313–322. doi: 10.1016/0006-2952(74)90422-5. [DOI] [PubMed] [Google Scholar]
  3. Breyer U., Schmalzing G. Metabolism and disposition of trifluoperazine in the rat. I. A thin-layer chromatographic method for the measurement of trifluoperazine and its metabolites in rat tissues. Drug Metab Dispos. 1977 Mar-Apr;5(2):97–103. [PubMed] [Google Scholar]
  4. Curry S. H., Whelpton R., de Schepper P. J., Vranckx S., Schiff A. A. Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man. Br J Clin Pharmacol. 1979 Apr;7(4):325–331. doi: 10.1111/j.1365-2125.1979.tb00941.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. ERLANGER B. F., BOREK F., BEISER S. M., LIEBERMAN S. Steroid-protein conjugates. I. Preparation and characterization of conjugates of bovine serum albumin with testosterone and with cortisone. J Biol Chem. 1957 Oct;228(2):713–727. [PubMed] [Google Scholar]
  6. ERLANGER B. F., BOREK F., BEISER S. M., LIEBERMAN S. Steroid-protein conjugates. II. Preparation and characterization of conjugates of bovine serum albumin with progesterone, deoxycorticosterone, and estrone. J Biol Chem. 1959 May;234(5):1090–1094. [PubMed] [Google Scholar]
  7. Eggert Hansen C., Rosted Christensen T., Elley J., Bolvig Hansen L., Kragh-Sorensen P., Larsen N. E., Naestoft J., Hvidberg E. F. Clinical pharmacokinetic studies of perphenazine. Br J Clin Pharmacol. 1976 Oct;3(5):915–923. doi: 10.1111/j.1365-2125.1976.tb00647.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hubbard J. W., Midha K. K., McGilveray I. J., Cooper J. K. Radioimmunoassay for psychotropic drugs I: synthesis and properties of haptens for chlorpromazine. J Pharm Sci. 1978 Nov;67(11):1563–1571. doi: 10.1002/jps.2600671118. [DOI] [PubMed] [Google Scholar]
  9. Jørgensen A. A sensitive and specific radioimmunoassay for cis (Z)-flupenthixol in human serum. Life Sci. 1978 Oct 16;23(15):1533–1542. doi: 10.1016/0024-3205(78)90580-5. [DOI] [PubMed] [Google Scholar]
  10. Kawashima K., Dixon R., Spector S. Development of radioimmunoassay for chlorpromazine. Eur J Pharmacol. 1975 Jun-Jul;32(02):195–202. doi: 10.1016/0014-2999(75)90283-6. [DOI] [PubMed] [Google Scholar]
  11. Loo J. C., Midha K. K., McGilveray I. J. Pharmacokinetics of chlorpromazine in normal volunteers. Commun Psychopharmacol. 1980;4(2):121–129. [PubMed] [Google Scholar]
  12. Midha K. K., Cooper J. K., Hubbard J. W. Radioimmunoassay for fluphenazine in human plasma. Commun Psychopharmacol. 1980;4(2):107–114. [PubMed] [Google Scholar]
  13. Midha K. K., Loo J. C., Hubbard J. W., Rowe M. L., McGilveray I. J. Radioimmunoassay for chlorpromazine in plasma. Clin Chem. 1979 Jan;25(1):166–168. [PubMed] [Google Scholar]
  14. Midha K. K., Mackonka C., Cooper J. K., Hubbard J. W., Yeung P. K. Radioimmunoassay for perphenazine in human plasma. Br J Clin Pharmacol. 1981 Jan;11(1):85–88. doi: 10.1111/j.1365-2125.1981.tb01107.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schmalzing G., Breyer U. Kinetics of [3H]trifluoperazine in bile fistula rats. Xenobiotica. 1978 Jan;8(1):45–54. doi: 10.3109/00498257809060382. [DOI] [PubMed] [Google Scholar]
  16. Schmalzing G. Metabolism and disposition of trifluoperazine in the rat. II. Kinetics after oral and intravenous administration in acutely and chronically treated animals. Drug Metab Dispos. 1977 Mar-Apr;5(2):104–115. [PubMed] [Google Scholar]
  17. West N. R., Vogel W. H. Absorption, distribution and excretion of trifluoperazine in rats. Arch Int Pharmacodyn Ther. 1975 Jun;215(2):318–335. [PubMed] [Google Scholar]
  18. Wiles D. H., Franklin M. Radioimmunoassay for fluphenazine in human plasma. Br J Clin Pharmacol. 1978 Mar;5(3):265–268. doi: 10.1111/j.1365-2125.1978.tb01636.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wiles D. H., Gelder M. G. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate. Br J Clin Pharmacol. 1979 Dec;8(6):565–570. doi: 10.1111/j.1365-2125.1979.tb01045.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES